EA200600939A1 - Фармацевтический препарат, содержащий габапентин - Google Patents
Фармацевтический препарат, содержащий габапентинInfo
- Publication number
- EA200600939A1 EA200600939A1 EA200600939A EA200600939A EA200600939A1 EA 200600939 A1 EA200600939 A1 EA 200600939A1 EA 200600939 A EA200600939 A EA 200600939A EA 200600939 A EA200600939 A EA 200600939A EA 200600939 A1 EA200600939 A1 EA 200600939A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutical preparation
- preparation containing
- gabapentin
- containing gabapentin
- peg
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 title abstract 6
- 229960002870 gabapentin Drugs 0.000 title abstract 3
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000008187 granular material Substances 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Приводится описание гранулята габапентина, полученного путем гранулирования габапентина с ПЭГ, имеющим температуру плавления в пределах от 50 до 80°С, и содержащих его фармацевтических композиций.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT002399A ITMI20032399A1 (it) | 2003-12-09 | 2003-12-09 | Composizione farmaceutica contenente gabapentina. |
PCT/EP2004/053233 WO2005055993A2 (en) | 2003-12-09 | 2004-12-02 | Pharmaceutical preparation containing gabapentin |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200600939A1 true EA200600939A1 (ru) | 2006-12-29 |
EA012068B1 EA012068B1 (ru) | 2009-08-28 |
Family
ID=34674559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200600939A EA012068B1 (ru) | 2003-12-09 | 2004-12-02 | Фармацевтический препарат, содержащий габапентин |
Country Status (21)
Country | Link |
---|---|
US (2) | US20080194687A1 (ru) |
EP (1) | EP1699438B1 (ru) |
JP (1) | JP5432433B2 (ru) |
CN (1) | CN100508966C (ru) |
AT (1) | ATE506052T1 (ru) |
AU (1) | AU2004296561B2 (ru) |
BR (1) | BRPI0417420B1 (ru) |
CA (1) | CA2546476C (ru) |
DE (1) | DE602004032382D1 (ru) |
DK (1) | DK1699438T3 (ru) |
EA (1) | EA012068B1 (ru) |
ES (1) | ES2363503T3 (ru) |
HR (1) | HRP20110346T1 (ru) |
IL (1) | IL175764A (ru) |
IT (1) | ITMI20032399A1 (ru) |
NZ (1) | NZ547764A (ru) |
PL (1) | PL1699438T3 (ru) |
PT (1) | PT1699438E (ru) |
SI (1) | SI1699438T1 (ru) |
WO (1) | WO2005055993A2 (ru) |
ZA (1) | ZA200604717B (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009044426A1 (ja) * | 2007-10-02 | 2009-04-09 | Shimadzu Corporation | 分取精製装置 |
USD657242S1 (en) | 2010-01-14 | 2012-04-10 | S.C. Johnson & Son, Inc. | Container with nozzle |
WO2017204582A1 (en) * | 2016-05-27 | 2017-11-30 | Hanmi Pharm. Co., Ltd. | Pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof inhibiting growth of cancer cells and a stabilizer having low melting point |
RU2731536C1 (ru) * | 2019-07-30 | 2020-09-04 | Общество С Ограниченной Ответственностью "Консорциум-Пик" | Фармацевтические композиции, содержащие фенозановую кислоту |
RU2736479C1 (ru) * | 2019-07-30 | 2020-11-17 | Общество С Ограниченной Ответственностью "Консорциум-Пик" | Не содержащая наполнитель фармацевтическая композиция, содержащая фенозановую кислоту |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE621097A (ru) * | 1961-08-05 | |||
US3147187A (en) * | 1962-09-10 | 1964-09-01 | Don Hall Lab | Sustained release pharmaceutical |
JPS58214333A (ja) * | 1982-06-04 | 1983-12-13 | Dai Ichi Seiyaku Co Ltd | 粒状物 |
US4443428A (en) * | 1982-06-21 | 1984-04-17 | Euroceltique, S.A. | Extended action controlled release compositions |
US5169645A (en) * | 1989-10-31 | 1992-12-08 | Duquesne University Of The Holy Ghost | Directly compressible granules having improved flow properties |
US5078990A (en) * | 1990-07-13 | 1992-01-07 | Helene Curtis, Inc. | Shampoos and conditioning shampoos having increased capacity for incorporation of conditioning agents and removal of hair soil |
US5232704A (en) * | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
US5429825A (en) * | 1992-06-26 | 1995-07-04 | Mcneil-Ppc, Inc. | Rotomelt granulation |
MX9707585A (es) * | 1995-04-03 | 1997-12-31 | Abbott Lab | Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada. |
DE69828635T2 (de) * | 1997-09-19 | 2005-06-16 | Shire Laboratories, Inc. | Feste lösungskügelchen |
BR9910494B1 (pt) * | 1998-05-15 | 2011-11-01 | composições sólidas contendo derivados de ácido gama-aminobutìrico e processo para o seu preparo. | |
IL125244A (en) | 1998-07-07 | 2002-12-01 | Yissum Res Dev Co | Pharmaceutical compositions containing low-melting waxes |
FR2781793B1 (fr) * | 1998-08-03 | 2001-07-20 | Prographarm Lab | Procede de fabrication de granules de gabapentine enrobes |
US7374779B2 (en) | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US20020015730A1 (en) * | 2000-03-09 | 2002-02-07 | Torsten Hoffmann | Pharmaceutical formulations and method for making |
US7056951B2 (en) * | 2000-09-26 | 2006-06-06 | Mutual Pharmaceutical Co., Inc. | Stable solid dosage forms of amino acids and processes for producing same |
EP1238662B1 (en) * | 2001-03-07 | 2006-05-31 | Dainippon Sumitomo Pharma Co., Ltd. | Method for manufacturing drug granules, the drug granules and pharmaceutical preparation containing the drug granules |
ITMI20011337A1 (it) | 2001-06-26 | 2002-12-26 | Farmatron Ltd | Composizioni farmaceutiche orali a rilascio modificato del principio attivo |
TWI312285B (en) * | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
EP1485344A1 (en) | 2002-03-28 | 2004-12-15 | Synthon B.V. | Venlafaxine besylate |
EP1558218A1 (en) * | 2002-10-08 | 2005-08-03 | Ranbaxy Laboratories Limited | Gabapentin tablets and methods for their preparation |
-
2003
- 2003-12-09 IT IT002399A patent/ITMI20032399A1/it unknown
-
2004
- 2004-12-02 DE DE602004032382T patent/DE602004032382D1/de active Active
- 2004-12-02 SI SI200431665T patent/SI1699438T1/sl unknown
- 2004-12-02 US US10/581,367 patent/US20080194687A1/en not_active Abandoned
- 2004-12-02 NZ NZ547764A patent/NZ547764A/en unknown
- 2004-12-02 CA CA2546476A patent/CA2546476C/en active Active
- 2004-12-02 AT AT04804655T patent/ATE506052T1/de active
- 2004-12-02 EA EA200600939A patent/EA012068B1/ru unknown
- 2004-12-02 EP EP04804655A patent/EP1699438B1/en active Active
- 2004-12-02 DK DK04804655.1T patent/DK1699438T3/da active
- 2004-12-02 CN CNB2004800366347A patent/CN100508966C/zh active Active
- 2004-12-02 WO PCT/EP2004/053233 patent/WO2005055993A2/en active Application Filing
- 2004-12-02 BR BRPI0417420-8A patent/BRPI0417420B1/pt active IP Right Grant
- 2004-12-02 PT PT04804655T patent/PT1699438E/pt unknown
- 2004-12-02 JP JP2006543535A patent/JP5432433B2/ja active Active
- 2004-12-02 PL PL04804655T patent/PL1699438T3/pl unknown
- 2004-12-02 AU AU2004296561A patent/AU2004296561B2/en active Active
- 2004-12-02 ES ES04804655T patent/ES2363503T3/es active Active
-
2006
- 2006-05-18 IL IL175764A patent/IL175764A/en active IP Right Grant
- 2006-06-08 ZA ZA200604717A patent/ZA200604717B/xx unknown
-
2011
- 2011-04-06 US US13/081,036 patent/US8927017B2/en active Active
- 2011-05-10 HR HR20110346T patent/HRP20110346T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
JP5432433B2 (ja) | 2014-03-05 |
CN100508966C (zh) | 2009-07-08 |
HRP20110346T1 (hr) | 2011-06-30 |
EP1699438B1 (en) | 2011-04-20 |
WO2005055993A2 (en) | 2005-06-23 |
DE602004032382D1 (de) | 2011-06-01 |
ZA200604717B (en) | 2007-03-28 |
NZ547764A (en) | 2009-09-25 |
ITMI20032399A1 (it) | 2005-06-10 |
IL175764A0 (en) | 2008-04-13 |
WO2005055993A3 (en) | 2006-05-26 |
AU2004296561B2 (en) | 2009-02-26 |
PT1699438E (pt) | 2011-07-05 |
US20080194687A1 (en) | 2008-08-14 |
ES2363503T3 (es) | 2011-08-05 |
BRPI0417420A (pt) | 2007-03-06 |
CA2546476C (en) | 2012-01-31 |
PL1699438T3 (pl) | 2011-10-31 |
EP1699438A2 (en) | 2006-09-13 |
CA2546476A1 (en) | 2005-06-23 |
IL175764A (en) | 2012-08-30 |
JP2007513920A (ja) | 2007-05-31 |
CN1889934A (zh) | 2007-01-03 |
ATE506052T1 (de) | 2011-05-15 |
DK1699438T3 (da) | 2011-08-15 |
SI1699438T1 (sl) | 2011-09-30 |
US20110189272A1 (en) | 2011-08-04 |
BRPI0417420B1 (pt) | 2021-10-13 |
US8927017B2 (en) | 2015-01-06 |
EA012068B1 (ru) | 2009-08-28 |
AU2004296561A1 (en) | 2005-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0311693A (pt) | Sal de formato de o-desmetil-venlafaxina | |
EA200601468A1 (ru) | Частицы | |
RS51694B (en) | NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE | |
EA200300873A1 (ru) | Новая соль сукцинат o-десметилвенлафаксина | |
EA200201271A1 (ru) | Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1 | |
ATE509634T1 (de) | Pharmazeutische formulierungen mit incretin- peptid und aprotisch-polarem lösungsmittel | |
HN2002000152A (es) | Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco | |
BR0110573A (pt) | Composto, composição farmacêutica que compreende esse composto, processo para a preparação de uma composição farmacêutica, utilização do composto e processo para o tratamento profilático ou terapêutico e para a preparação do composto | |
SG10201809390QA (en) | Modulators of indoleamine 2,3-dioxygenase and methods of using the same | |
DE69906084D1 (de) | Ibuprofen enthaltende schnelllösliche zusammensetzungen mit analgetischer wirkung | |
EA200400819A1 (ru) | Парентеральная композиция парацетамола | |
EA200501821A1 (ru) | Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат | |
EA200600939A1 (ru) | Фармацевтический препарат, содержащий габапентин | |
IS6654A (is) | Stöðugt gabapentín með pH innan stýrðra marka | |
EA200501046A1 (ru) | Эсциталопрамгидробромид и способ его получения | |
ATE464043T1 (de) | Pharmazeutische zusammensetzung enthaltend l- arginin | |
DE60317565D1 (de) | Pharmazeutische zusammensetzungen mit insulin und insulin-hexamer-liganden | |
TW200514571A (en) | Pharmaceutical composition with improved solubility and fluidity | |
BRPI0413777A (pt) | composições de modafinil | |
EA200501088A1 (ru) | Цетилпиридиниевая соль противоспалительного средства и фармацевтические композиции, содержащие ее | |
TW200509941A (en) | Pharmaceutical solution composition | |
ITMI20030827A1 (it) | Composizione farmaceutica contenente l'associazione levodopa/carbidopa. | |
EA200401082A1 (ru) | Новые соединения бензоиндолина, способ их получения и фармацевтические композиции, которые их содержат | |
EA200400954A1 (ru) | Фармацевтическая композиция, содержащая 2,2-дихлор-12-(4-хлорфенил)додекановую кислоту | |
ATE395055T1 (de) | Pharmazeutische zusammensetzung zur behandlung von hyperhomocysteinämie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC1A | Registration of transfer to a eurasian application by force of assignment |